IL10 and Menkes disease: In addition, ROC curve analysis showed that the AUC of IL-17/IL-10 ratio used to diagnose hearing stage III or above in MD patients was 0.8731, which indicated that NLRP6 had a high diagnostic value for the severity of hearing abnormality in MD patients.